Document:

Exhibit 10.1

 

FIRST
AMENDMENT TO subscription Agreement

 

This First Amendment
(this "Amendment") to the Subscription Agreement by and between Net Element, Inc., a Delaware corporation
(the “Company”), and Kenges Rakishev (the “Buyer”), dated as of February
23, 2012 (the "Agreement"), is effective as of the 19th day of
April, 2012 (the “Amendment Effective Date”).  

 

RECITALS

 

WHEREAS, the
Company and Buyer desire to amend certain terms of the Agreement as set forth herein, and, except as otherwise provided below,
intend that the Agreement shall remain in full force and effect.

 

NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of the Company and Buyer
agrees that the Agreement shall be amended as follows:

 

1.          The
foregoing recitals are hereby acknowledged to be true and accurate and are incorporated herein by this reference. Unless otherwise
provided herein all terms appearing in initial capitalized letters shall have the meanings ascribed to them in the Agreement.

 

2.          The
first sentence of Section 4(j) of the Agreement is hereby deleted in its entirety and replaced with the following:

 

“From
the date hereof through the first date after April 23, 2012, on which the Buyer, together with Buyer’s Affiliates, cease
to have “beneficial ownership” (as determined under Section 13(d) of the 1934 Act and the rules and regulations thereunder)
greater than five percent (5%) of the Common Stock, the Company and each Subsidiary shall be prohibited from effecting or entering
into an agreement to effect any Subsequent Placement (as defined below) involving a Variable Rate Transaction.”

 

3.          Section
4(k) of the Agreement is hereby deleted in its entirety and replaced with the following:

 

“(k)      Certain
Defined Terms. (i) “Convertible Securities” means any capital stock or other security of the Company or
any of its Subsidiaries that is, or may be, at any time and under any circumstances directly or indirectly convertible into, exercisable
or exchangeable for, or which otherwise entitles the holder thereof to acquire, any capital stock or other security of the Company
(including, without limitation, Common Stock) or any of its Subsidiaries; and (ii) “Subsequent Placement” means
any of the following by or on behalf of the Company or any of its Subsidiaries (whether directly or
indirectly): the issuance, offer, sale, grant of any option or right to purchase, or other disposition of (or announcement of any
issuance, offer, sale, grant of any option or right to purchase or other disposition of) any equity security or any equity-linked
or related security (including, without limitation, any “equity security” (as that term is defined under Rule 405 promulgated
under the 1933 Act), any Convertible Securities, any preferred stock or any purchase rights.”

 

    	 

    	 

    

 

4.          This
Amendment will be effective from and after the Amendment Effective Date and in the event of any conflict between the terms of the
Agreement and the terms of this Amendment, the terms of this Amendment shall control with respect to all matters from and after
the Amendment Effective Date. Except as expressly set forth herein, (i) each of the Transaction Documents and each of the obligations
and rights of the Company thereunder, and each of the rights and obligations of and benefits to Buyer thereunder, is, and shall
continue to be, in full force and effect and each is hereby ratified and confirmed in all respects, except that from and after
the date hereof, without implication that the contrary would otherwise be true, (A) all references in the Agreement to “this
Agreement,” “hereto,” “hereof,” “hereunder” or words of like import referring to the
Agreement shall mean the Agreement as amended by this Amendment and (B) all references in the Transaction Documents to “the
Subscription Agreement,” “thereto,” “thereof,” “thereunder” or words of like import referring
to the Transaction Documents shall mean the Agreement as amended by this Amendment and (ii) the execution, delivery and effectiveness
of this Amendment shall not operate as an amendment or waiver of any right, power or remedy of Buyer or the Company under any of
the Transaction Documents, nor constitute an amendment or waiver of any provision of any of the Transaction Documents and each
of the Transaction Documents shall continue in full force and effect, as amended or modified by this Amendment. The parties hereto
agree that this Amendment (i) amends (and constitutes an amendment to) all the Transaction Documents as expressly contemplated
by this Amendment to give full force and effect to the terms and conditions of this Amendment and (ii) constitutes a “Transaction
Document” for purposes of all Transaction Documents.

 

5.          All
of the terms and conditions herein contained shall be binding upon and inure to the benefit of the parties and their respective
successors and assigns.

 

6.          This
Amendment shall be governed by the internal laws of the State of Delaware, without giving effect to any choice of law or conflict
of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would cause the application of the
laws of any jurisdictions other than the State of Delaware.

 

7.          This
Amendment may be executed in multiple counterparts, each of which shall be deemed an original but all of which, together, shall
constitute one instrument. For the purposes of this Amendment, an executed facsimile or a portable document format (.PDF) counterpart
copy of this Amendment shall be deemed an original for all purposes.

 

8.          The
Company shall, on or before 8:30 a.m., New York time, on the 4th Business Day (as defined in the Agreement) after the
Amendment Effective Date, file a Current Report on Form 8-K describing all the material terms of the transactions contemplated
by this Amendment in the form required by the 1934 Act.

 

[Signature page follows.]

 

    	 

    	 

    

 

IN WITNESS WHEREOF,
the Company and Buyer have executed this Amendment effective as of the Amendment Effective Date.

 

	 	COMPANY:
	 	 
	 	NET ELEMENT, INC.
	 	 
	 	By:	/s/ Jonathan New
	 	 	Name:	Jonathan New
	 	 	Title:	CFO
	 	 	 	 
	 	BUYER:
	 	 
	 	/s/ Kenges Rakishev
	 	KENGES RAKISHEV

 

[Signature page to First Amendment to
Subscription Agreement]Exhibit 10.26

 

April 20, 2012

 

Melissa A. Waterhouse

PO Box 769

Philmont, New York 12565

 

Dear Melissa,

 

It is our pleasure to formally offer you the position of Executive
Vice President and Chief Compliance Officer of American Bio Medica Corporation (“ABMC” or the “Company”),
reporting directly to the ABMC Chief Executive Officer. This agreement supersedes all other agreements whether written or verbal
and may not be amended except by a writing signed by you and the Chief Executive Officer, and approved by the Board of Directors.
Your position will be primarily located at our New York corporate facility although overnight travel may be required from time
to time. You will perform all duties as are generally associated with the position of Executive Vice President and Chief Compliance
Officer, as directed by the Chief Executive Officer. Below, we have outlined the major terms and conditions applicable to your
position.

 

Term

 

Your employment with ABMC will be for a term of one year unless
sooner terminated for cause, beginning on the date set forth above and automatically renewed for successive one-year terms unless
either side gives written notice of intent not to renew at least sixty (60) days prior to the end of any one-year term. If AMBC
terminates your employment for cause, this agreement shall be terminated and you will be entitled to no severance and no further
compensation or benefits from ABMC, other than payment of salary and benefits up to and including the date of termination.

 

Compensation

 

Effective with the signing of this letter, your base salary
will remain $8,333 per month, which is equivalent to $100,000 on an annualized basis. You will be eligible for your first performance
review by the Board of Directors in October 2012.

 

If you so desire, the cost of your health insurance (including
family coverage if you so require) shall be borne 100% by the Company. Please notify Human Resources if you wish to receive this
benefit.

 

You shall participate in the Management Bonus Program as approved
by the Board of Directors on January 19, 2005, and as amended by the Board of Directors on November 9, 2005.

 

Benefits

 

	 	20 vacation days
	 	Usual corporate holidays
	 	2 personal days
	 	401 (k)

 

    	 

    	 

    

 

Severance

 

In the unlikely event that ABMC elects to terminate your employment
for anything other than cause, you will receive severance pay equal to twelve (12) months of your current base salary at the time
of separation, with continuation of all medical benefits during the twelve-month period at ABMC’s expense. Cause shall be
defined as (1) death, (2) commission of a felony (3) acts of dishonesty, fraud or malfeasance in connection with your service on
behalf of the Company, (4) gross dereliction of duty willful failure to carry out any lawful directive of the Chief Executive Officer
or the Board of Directors, or material violations of Company policies which continue after Company has provided you with written
notice thereof and a period of thirty (30) days to cure such action or misconduct or (5) disability of a period of more than six
(6) months). The severance payment will be made under the current pay cycle, each pay period, during the twelve (12) months, subject
to all customary withholdings.

 

Additionally, you may resign your position and elect to exercise
this severance provision at your option under the following circumstances:

 

If you are required to relocate by the Company or
its Board of Directors more than 50 miles from the Company’s Kinderhook facility as a condition of continued employment

 

A substantial change in responsibilities normally
assumed by an Executive Vice President/Chief Compliance Officer at the direction of the Company or its Board of Directors (i.e.
demotion)

 

You are asked to commit or conceal the commitment
of any illegal act by any officer or member of the board of directors of the Company.

 

Change in Control

 

If there is a Change in Control (defined below) of ABMC, you
may elect to resign your position and to receive a lump sum severance payment equal to two (2) times your annual base salary (“CIC
Payment”). If you elect to resign, ABMC will pay you the CIC Payment within thirty (30) days after you make your election,
which election must be in writing and received by ABMC’s Board of Directors within ten (10) days after a Change in Control.
In the event you continue employment with ABMC or any successor to ABMC following a Change in Control or fail to make an election
within ten (10) days after a Change in Control, you will not be entitled to receive the CIC Payment.

 

Change in Control is defined as follows:

 

(i) the approval by shareholders of ABMC of a merger
or consolidation of ABMC with any other corporation, other than a merger or consolidation which would result in the voting securities
of ABMC outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into
voting securities of the surviving entity) more than fifty percent (50%) of the total voting power represented by the voting securities
of ABMC or such surviving entity outstanding immediately after such merger or consolidation; or

 

(ii) the approval by the shareholders of ABMC of a
plan of complete liquidation of ABMC or an agreement for the sale or disposition by ABMC of all or substantially all of ABMC’s
assets.

 

    	 

    	 

    

 

Restrictive Covenants

 

Company Handbook/Compliance Certification

 

You are aware that it is your responsibility to read the ABMC
Employee Handbook thoroughly and comply with the policies contained in the Handbook. You understand that the policies, benefits
and information contained in the Handbook are subject to change and that revisions to the Handbook may be made. Any such changes
will be communicated through official written notices and you hereby acknowledge that any such revisions may supercede, modify
or eliminate existing policies. Only a majority of the Executive Officers, or a majority of the Board of Directors may adopt revisions
to the policies contained in the Handbook. In no circumstance may a change to the employee handbook reduce the salary, benefits
or other conditions outlined in this employment agreement.

 

You agree that in addition to any covenants included in this
Employment Letter, you will sign a Compliance Certification simultaneously with the signing of this Employment Letter. If a conflicting
covenant exists between the Employment Letter and the Compliance Certification and/or the Company Handbook, the Employment Letter
shall be the ruling document.

 

Non-Solicitation

 

During the twelve (12) months immediately following your termination
from employment with ABMC for any reason, you agree that:

 

You will not, directly or indirectly, solicit in any manner
or capacity whatsoever, including by way of illustration, but not limitation, call upon, mail or e-mail notices to, or make telephone
calls to, any Customer (defined below) or Customer Prospect (defined below) of ABMC, for the purpose of selling any Covered Services
(defined below) or engaging in any business which directly or indirectly competes with ABMC.

 

You will not solicit, endeavor to entice away from ABMC, or
otherwise interfere with the relationship of ABMC with any person who is employed (or, but for any violation of this agreement,
would have been employed) by or otherwise engaged to perform services for ABMC, whether for your own account or for the account
of any other person or entity.

 

You will not, directly or indirectly, solicit in any manner
or capacity whatsoever, including by way of illustration, but not limitation, call upon, mail, or e-mail notices to, or make telephone
call to, any supplier or vendor of ABMC for the purpose of engaging in any business which directly or indirectly competes with
ABMC.

 

Confidentiality

 

You agree not to disclose any Confidential Information (defined
below) and you promise to take all reasonable precautions to prevent its unauthorized dissemination, both at all times during your
employment with ABMC and after termination of your employment for any reason. You agree to limit the disclosure of any Confidential
Information to only those employees and agents of ABMC who have a need to know the information and who have similarly agreed to
keep such information confidential. Upon termination of your employment or upon request, you will deliver to ABMC all documents
and electronic files containing Confidential Information and any personal property owned by ABMC.

 

    	 

    	 

    

 

You further agree not to use any Confidential Information for
your own benefit or for the benefit of anyone other than ABMC. You acknowledge that all Confidential Information is and remains
the property of ABMC and that no license or rights in the Confidential Information has been or is granted to you.

 

“Confidential Information" means and includes all
information not previously known by you prior to your employment with ABMC relating to marketing, advertising, public relations,
development, services, trade secrets, trade "know-how," business plans, Customer (as defined below) and Customer Prospect
(as defined below) lists, distributor lists, Customers and Customer Prospects information, distributor information, financial data,
personnel data, employee compensation and benefits information, new personnel acquisition plans, details of contracts, pricing
policies, operational methods, marketing plans or strategies, service development techniques or plans, business acquisition or
investment plans, or other confidential and proprietary information related to the business or affairs of ABMC and/or its Customers
or Customer Prospects.

 

The term "Customer" means any person or entity for
which ABMC performed any Covered Services during the one (1) year period immediately preceding the termination of your employment
with ABMC for any reason whatsoever.

 

"Customer Prospect" means any person or entity to
which ABMC made a new business presentation or proposal, whether formal or informal related to Covered Services during the one
(1) year period immediately preceding the termination of your employment with ABMC for any reason whatsoever.

 

“Covered Services” means any services or products
of whatever kind or character offered or provided by ABMC to any person or entity.

 

Enforcement

 

If any provision of the covenants in this agreement shall be
held invalid or unenforceable, the remainder nevertheless shall remain in full force and effect. If any provision is held invalid
or unenforceable with respect to particular circumstances, it nevertheless shall remain in full force and effect in all other circumstances.

 

If, in connection with any action taken by ABMC to enforce the
provisions of the covenants of this agreement, a court shall hold that all or any portion of the restrictions contained therein
are unreasonable under the circumstances then existing so as to render such covenants invalid or unenforceable, the parties agree
that any court of competent jurisdiction may reform such unreasonable restrictions to the extent necessary to make such restrictions
reasonable under the circumstances then existing so as to render such restrictions both valid and enforceable.

 

You acknowledge and agree that all of the covenants contained
in this agreement are necessary for the protection of ABMC's valuable and legitimate business interests and are reasonable in scope
and content. Accordingly, you acknowledge and agree that if you violate any of the provisions of this agreement ABMC shall sustain
irreparable harm and, therefore, in addition to the other remedies which ABMC may have under this agreement or otherwise, ABMC
will be entitled to specific performance, injunctive, and other equitable relief.

 

    	 

    	 

    

 

You agree to indemnify, save and hold harmless ABMC from and
against any and all claims, damages, losses, costs and expenses (including reasonable attorneys' fees) incurred by ABMC in any
action in which a court enforces the terms of the covenants of this agreement.

 

Other Employment Information

 

In making this offer of continued employment, ABMC has relied
on your representations that: (a) you are not currently a party to any contract of employment that might impede your ability to
accept this offer or to perform the services completed thereby; and (b) that you are not subject to any non-competition arrangement
or other restrictive covenants that might restrict your employment at ABMC as contemplated by this offer.

 

Exclusive Service

 

You will perform services exclusively for ABMC and you will
not perform services for any other persons or entities related to or conducting business with the Company for personal profit during
the term of this agreement without the written agreement of the Chief Executive Office or Board of Directors.

 

Miscellaneous

 

This writing represents the entire agreement with respect to
your employment and any prior agreements or understandings, written or oral, are merged herein. This agreement shall be governed
by the laws of the State of New York. ABMC will not be deemed to have waived any provision of this agreement except by a signed
writing. This agreement may not be amended, except by a signed writing. Notices given pursuant to this Agreement shall be in writing
and delivered personally or by nationally recognized overnight courier in the case of ABMC to its Kinderhook facility to the attention
of the Chief Executive Officer and in your case to your home address as set forth in ABMC’s personnel file.

 

Melissa, we are enthusiastic about your appointment as Executive
Vice President and Chief Compliance Officer, and our expectation is that you will continue to make a tremendous contribution to
the long-term success of ABMC.

 

Sincerely,

 

	/s/ Stan Cipkowski	 
	Stan Cipkowski	 
	Chief Executive Officer	 
	By order of the American Bio Medica Corporation Board of Directors
	 	 
	Accepted this 23rd Day of April, 2012:	 
	 	 
	/s/ Melissa A. Waterhouse	 
	Melissa A. Waterhouse

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00203-of-00352.parquet"}]]